查詢結果分析
相關文獻
- Extra-corporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: A Single Center Experience
- 照顧一位溺水患者成功脫離呼吸之加護經驗
- 急性小兒呼吸衰竭體外維生系統的應用
- 敗血性休克的致病機轉和治療之探討:生理、生化、藥物和藥理的角度
- 加護病房內急性呼吸窘迫症候群的探討
- 口腔顎顏面外科領域之致命性併發症--成人呼吸窘迫症候群
- 恙蟲病併發急性呼吸窘迫症候群
- Factors Associated with High-frequency Oscillatory Ventilation Response in Infants with Respiratory Failure
- 敗血性休克合併非少尿性急性腎衰竭
- Acute Respiratory Distress Syndrome Complicating Generalized Pustular Psoriasis
頁籤選單縮合
題 名 | Extra-corporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: A Single Center Experience=以體外維生系統治療急性呼吸窘迫症候群:單一醫院之經驗 |
---|---|
作 者 | 吳協兆; 陳銘仁; 孫珅; 李君儀; | 書刊名 | Acta Cardiologica Sinica |
卷 期 | 23:2 2007.06[民96.06] |
頁 次 | 頁97-102 |
分類號 | 415.47 |
關鍵詞 | 急性呼吸窘迫症候群; 體外維生系統; 敗血性休克; Acute respiratory distress syndrome; Extracorporeal membrane oxygenation; Septic shock; |
語 文 | 英文(English) |
中文摘要 | 背景 急性呼吸窘迫症候群常伴隨有相當高的併發症與死亡率。我們報告對於重度急性呼吸窘迫症候群病患以體外維生系統的治療結果。 病患與方法 從2001年12月至2005年7月,共有10位病患因急性呼吸窘迫症候群(或合併敗血性休克)接受體外維生系統的治療。六位男性病患,四位女性病患,年齡的中位數為4.3歲(範圍:2.1至71歲)。對於低血氧合併有低血壓的病患,使用靜脈動脈型的體外維生系統;對於低血氣但無低血壓的病患,使用靜脈靜脈型的體外維生系統。 結果 五位病患(50%)可成功脫離體外維生系統。體外維生系統治療的成功率在2001年至2002年為20%(1/5),在2003年至2005年為80%。體外維生系統使用期間的中位數為89小時。病患死亡的原因如下:兩位缺氧性腦病變、一位顱內出血、一位肺功能持續惡化、一位敗血症無法控制。所有五位成功脫離體外維生系統的病患都可順利出院。 結論 對於重度急性呼吸窘迫症候群病患,甚至在敗血性休克的情況下,體外維生系統的使用有機會可抗救病患的生命。文獻上可見治療的結果逐漸有改善,而我們的報告亦有相似的趨勢。對於重度急性呼吸窘迫症候群病息,無法以傳統治療穩定病情時,體外維生系統可提供一線生存的機會。 |
英文摘要 | Background: Acute respiratory distress syndrome (ARDS) is associated with high morbidity and mortality rate. We report our treatment results with extracorporeal membrane oxygenation for severe ARDS patients. Patients and Methods: From December 2001 through July 2005, there were 10 patients receiving treatment of extracorporeal membrane oxygenation (ECMO) for ARDS and/or septic shock in our hospital. There were six male and four female patients. The median age at the time of ECMO support was 4.3 years old (range: 2.1-71). Venoarterial-ECMO was used for the patients with severe desaturation and persistent hypotension, and venovenous-ECMO was used for the patients with severe desaturation but preserved cardiac function. Results: Five patients (50%) survived the ECMO. The ECMO survival rate was 20% (1/5) between 2001 and 2002, and was 80% (4/5) between 2003 and 2005. The median ECMO supporting time was 89 hours. The cause of mortality was hypoxic encephalopathy in 2 patients, intra-cranial hemorrhage in 1 patient, deteriorated pulmonary function in 1 patient and uncontrolled sepsis in 1 patient. All the survived patients were discharged from the hospital. Conclusion: ECMO can rescue more patients with severe ARDS, even in the condition of septic shock. Improved results were reported in the literature, and our series also shows similar trend. For those patients with severe ARDS whose conditions cannot be improved or even deteriorate under conventional therapy, ECMO can provide a chance of survival. |
本系統中英文摘要資訊取自各篇刊載內容。